[1]
“The Dysregulation of mir-21 and mir-143 as a clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients with Gastrointestinal Sarcoma”, Journal of Pharmaceutical Negative Results, vol. 13, no. 3, pp. 20–25, Sep. 2022, doi: 10.47750/pnr.2022.13.03.004.